Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON to Participate in Upcoming Events in January

MADRID and CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics,...
January 08, 2026 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea informiert über Stand seines Portfolios und gibt Ausblick

Klinisches Portfolio gestärkt durch Einlizenzierung des Phase-3-bereiten Antibiotikums Ceftibuten-LedaborbactamZweite Phase-3-Studie mit Fosmanogepix gestartet; beide Phase-3-Studien in invasiven...
January 08, 2026 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea provides portfolio update and outlook

Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix second phase 3 study initiated; two phase 3 studies in invasive fungal...
January 07, 2026 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea und Prokaryotics starten Zusammenarbeit zur Entwicklung eines neuartigen Breitband-Antipilzmittels für die Behandlung schwerer invasiver Infektionen

Allschwil, 07. Januar 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patientinnen und Patienten zu helfen,...
January 07, 2026 01:15 ET | Source: Basilea Pharmaceutica AG, Allschwil

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
January 05, 2026 10:45 ET | Source: CLIQ Digital AG

Cliq Digital AG: Wirksamkeit des Segmentwechsels in das Basic Board des Freiverkehrs an der Frankfurter Wertpapierbörse zum 23. März 2026

Düsseldorf, 5. Januar 2026 – Wie mit Ad hoc-Mitteilung vom 12. Dezember 2025 angekündigt, hat die Cliq Digital AG („Gesellschaft“) die Einbeziehung ihrer Aktien in den Handel im Scale-Segment des...
January 05, 2026 10:45 ET | Source: CLIQ Digital AG

Cliq Digital AG: Effectiveness of the segment change to the Basic Board of the open market of the Frankfurt Stock Exchange as of 23 March 2026

Dusseldorf, 5 January 2026 – As previously announced by ad hoc announcement dated 12 December 2025, Cliq Digital AG (“Company”) terminated the listing of its shares in the Scale segment of the open...
December 30, 2025 17:00 ET | Source: Chibougamau Independent Mines Inc.

Chibougamau Independent Mines Completes “Flow-Through” Financing

ROUYN-NORANDA, Québec, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in...
December 23, 2025 09:00 ET | Source: Globex Mining Enterprises Inc.

Initial Drill Holes Returned Zn, Ag and Au Over Wide Widths on Globex Royalty Claims

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange,...
December 23, 2025 09:00 ET | Source: Chibougamau Independent Mines Inc.

Initial Drill Holes Returned Zn, Ag and Au Over Wide Widths on Chibougamau Independent Claims Optioned to TomaGold

ROUYN-NORANDA, Québec, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in...